Exicure, Inc. Profile Avatar - Palmy Investing

Exicure, Inc.

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic…

Biotechnology
US, Chicago [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of XCUR's Analysis
CIK: 1698530 CUSIP: 30205M101 ISIN: US30205M2008 LEI: - UEI: -
Secondary Listings
XCUR has no secondary listings inside our databases.